An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis

NCT01863238 · clinicaltrials.gov ↗

COMPLETED

Status

95

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

OTHER: Ophthalmologic examinations
DRUG: Ivacaftor Exposed

Sponsor

Vertex Pharmaceuticals Incorporated

Collaborators

[object Object]